Compugen Ltd SEC filings CGEN
Compugen Ltd has 607 filings in SEC EDGAR's recent list, going back to Feb 13, 2001. Its latest annual report, Form 20-F, was filed on Mar 2, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 10, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| F-3 | Shelf registration (foreign issuer) | May 18, 2026 | — |
| F-3/A | Filing | Jun 23, 2023 | — |
| F-3/A | Filing | Apr 14, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 30, 2023 | — |
| 424B5 | Prospectus supplement | Jan 31, 2023 | — |
| S-8 | Employee stock plan registration | Aug 4, 2022 | — |
| S-8 | Employee stock plan registration | Dec 10, 2020 | — |
| F-3 | Shelf registration (foreign issuer) | Jul 30, 2020 | — |
| S-8 | Employee stock plan registration | Jul 30, 2020 | — |
| 424B5 | Prospectus supplement | Mar 12, 2020 | — |
| 424B5 | Prospectus supplement | Mar 11, 2020 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 5, 2019 | — |
| 424B5 | Prospectus supplement | Jun 18, 2018 | — |
| 424B5 | Prospectus supplement | May 25, 2018 | — |
| S-8 | Employee stock plan registration | Mar 27, 2018 | — |
| 424B2 | Prospectus | Oct 14, 2016 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 9, 2016 | — |
| S-8 | Employee stock plan registration | Jun 11, 2015 | — |
| 424B2 | Prospectus | Sep 4, 2014 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 26, 2014 | — |
| 424B5 | Prospectus supplement | Feb 28, 2014 | — |
| 424B5 | Prospectus supplement | Feb 27, 2014 | — |
| 424B2 | Prospectus | Jan 16, 2013 | — |
| F-3 | Shelf registration (foreign issuer) | Jan 7, 2013 | — |
| 424B5 | Prospectus supplement | Sep 1, 2011 | — |
| 424B3 | Prospectus | Jan 25, 2011 | — |
| F-3 | Shelf registration (foreign issuer) | Jan 11, 2011 | — |
| S-8 | Employee stock plan registration | Sep 7, 2010 | — |
| POS AM | Pos-am | Jan 21, 2010 | — |
| 424B5 | Prospectus supplement | Oct 30, 2009 | — |
| F-3/A | Filing | Aug 11, 2009 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 11, 2009 | — |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CGEN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Holon, Israel
- SEC filer status
- Accelerated filer
- SEC CIK
- 1119774
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.